We found a significant interaction between BMI (<20.4 vs. ≥20.4 to ≤22.5 vs. ≥22.5, P for interaction <0.001) and AIP on the risk of NAFLD. This evidence concerns the gene AIP and metabolic dysfunction-associated steatotic liver disease.